Variant report
Variant | esv3398489 |
---|---|
Chromosome Location | chr7:129156058-129157171 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:129004405..129006916-chr7:129153752..129156146,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs56999169 | chr7:129156075-129156076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1248448 | chr7:129156076-129156077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71527910 | chr7:129156079-129156080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559380734 | chr7:129156100-129156101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552589390 | chr7:129156102-129156103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574090203 | chr7:129156148-129156149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113074710 | chr7:129156170-129156171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535199966 | chr7:129156172-129156173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373356076 | chr7:129156199-129156200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376502770 | chr7:129156280-129156281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575362493 | chr7:129156325-129156326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545950147 | chr7:129156329-129156330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564222825 | chr7:129156367-129156368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573135802 | chr7:129156464-129156465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540533518 | chr7:129156481-129156482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142865568 | chr7:129156502-129156503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34325468 | chr7:129156546-129156547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77786896 | chr7:129156568-129156569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9770842 | chr7:129156581-129156582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548716967 | chr7:129156596-129156597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs193146464 | chr7:129156602-129156603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185334337 | chr7:129156610-129156611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552699384 | chr7:129156611-129156612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570947708 | chr7:129156613-129156614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187728554 | chr7:129156618-129156619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546866177 | chr7:129156645-129156646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567751578 | chr7:129156650-129156651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535047405 | chr7:129156651-129156652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373852937 | chr7:129156664-129156665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556657832 | chr7:129156674-129156675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575250252 | chr7:129156675-129156676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570770267 | chr7:129156698-129156699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557981373 | chr7:129156699-129156700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376177224 | chr7:129156706-129156707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs62489129 | chr7:129156710-129156711 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs561932615 | chr7:129156740-129156741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557870636 | chr7:129156741-129156742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373926092 | chr7:129156744-129156745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574908399 | chr7:129156751-129156752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192534586 | chr7:129156785-129156786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551900208 | chr7:129156786-129156787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183689144 | chr7:129156792-129156793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531074762 | chr7:129156793-129156794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552386030 | chr7:129156794-129156795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564729164 | chr7:129156812-129156813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62489130 | chr7:129156827-129156828 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs188357554 | chr7:129156829-129156830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368235952 | chr7:129156830-129156831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568385191 | chr7:129156859-129156860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181025261 | chr7:129156877-129156878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Retinitis pigmentosa | 17160897 | CNVD |
Colorblindness | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:129150800-129175400 | Weak transcription | Right Atrium | heart |
2 | chr7:129152000-129162600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr7:129153800-129157800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr7:129154600-129159800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr7:129154800-129158800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr7:129154800-129159200 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr7:129154800-129159200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr7:129154800-129159400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr7:129154800-129162000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr7:129155000-129157600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr7:129155000-129159600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr7:129155000-129159600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
13 | chr7:129155200-129159600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr7:129156400-129157200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
15 | chr7:129156800-129157000 | Enhancers | Primary T cells fromperipheralblood | blood |